• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION IMPLANTABLE NEUROSTIMULATOR; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION IMPLANTABLE NEUROSTIMULATOR; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR Back to Search Results
Model Number NEU_INS_STIMULATOR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Erosion (1750); Purulent Discharge (1812); Erythema (1840); Unspecified Infection (1930); Inflammation (1932); Discomfort (2330); Alteration In Body Temperature (2682)
Event Date 06/07/2019
Event Type  Injury  
Manufacturer Narrative
Other relevant device(s) are: product id: neu_unknown_ext, serial/lot #: unknown.Product id: neu_ins_stimulator, serial/lot #: unknown.Product id: neu_ins_stimulator, serial/lot #: unknown.Product id: neu_ins_stimulator, serial/lot #: unknown.Product id: neu_ins_stimulator, serial/lot #: unknown.Product id: neu_ins_stimulator, serial/lot #: unknown.Product id: neu_ins_stimulator, serial/lot #: unknown.Age or date of birth: this value is the average age of the patients reported in the article as specific patients could not be identified.Sex: this value reflects the gender of the majority of the patients reported in the article as specific patients could not be identified.Date of event: please note that this date is based off of the date of publication of the article as the event dates were not provided in the published literature.Description of problem or event: it was not possible to ascertain specific device information from the article or to match the events reported with previously reported events.Correspondence has been sent to the author of the article inquiring about individual patient information and additional information regarding the reported events.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Atchley tj, laskay nmb, sherrod ba, rahman a, walker hc, guthrie bl.Reoperation for device infection and erosion following deep brain stimulation implantable pulse generator placement.J neurosurg.2019:1-8.10.3171/2019.3.Jns183023.Summary: infection and erosion following implantable pulse generator (ipg) placement are associated with morbidity and cost for patients with deep brain stimulation (dbs) systems.Here, the authors provide a detailed characterization of infection and erosion events in a large cohort that underwent dbs surgery for movement disorders.Reported events: 13 patients required ipg hardware removal due to infection within one year of implant.1 patient required ipg hardware removal due to infection one year beyond one year of implant.The infection was most likely related to the surgery itself and/or wound closure.The authors noted the use of vancomycin powder during stage 2 procedure did not decrease rate of hardware infection.27 patients required part or all of the extension wire to be removed due to infection.5 patients required ipg hardware removal due to coagulase-negative staphylococci.5 patients required ipg hardware removal due to pseudomonas aeruginosa.2 patients developed a second infection requiring a second re-operation on the same side.2 patients developed a third infection requiring a third re-operation on the same side.11 patients required ipg hardware removal due to erosion within one year of implant.1 patient required ipg hardware removal due to erosion one year beyond one year of implant.The erosion was related to chronic changes associated with friction, poor cushioning from the overlying soft tissue, or other patient-related factors.The authors noted that bmi was inversely related to the frequency of erosion.4 patients with required ipg hardware removal due to erosion, also associated with concomitant infection.The following device specifics were identified in the literature article: ins model 37601, 37602, 37603, and 7426.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE NEUROSTIMULATOR
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key8849053
MDR Text Key152923190
Report Number3007566237-2019-01679
Device Sequence Number1
Product Code MHY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P960009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 07/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEU_INS_STIMULATOR
Device Catalogue NumberNEU_INS_STIMULATOR
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/03/2019
Initial Date FDA Received07/31/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
-
-